Therapeutic efficacy and safety of oral propafenone for atrial fibrillation
- 1 January 1989
- journal article
- research article
- Published by Elsevier BV in The American Journal of Cardiology
- Vol. 63 (1), 114-116
- https://doi.org/10.1016/0002-9149(89)91091-6
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Propafenone for prevention of recurrent atrial fibrillationThe American Journal of Cardiology, 1988
- Propafenone for paroxysmal atrial fibrillationThe American Journal of Cardiology, 1988
- Sustained therapeutic efficacy and safety of oral propafenone for treatment of chronic ventricular arrhythmias: A 2-year experienceAmerican Heart Journal, 1988
- Double-blind study of intravenous propafenone for paroxysmal supraventricular reentrant tachycardiaJournal of the American College of Cardiology, 1987
- Usefulness of programmed stimulation in predicting efficacy of propafenone in long-term antiarrhythmic therapy for paroxysmal supraventricular tachycardiaThe American Journal of Cardiology, 1985
- Propafenone: A new agent for ventricular arrhythmiaJournal of the American College of Cardiology, 1984
- Clinical efficacy and electrophysiology of oral propafenone for ventricular tachycardiaThe American Journal of Cardiology, 1983
- Electrophysiological and Antiarrhythmic Properties of Propafenon in Isolated Cardiac PreparationsJournal of Cardiovascular Pharmacology, 1981